α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma.

Saved in:
Bibliographic Details
Title: α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma.
Authors: Sainz V; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Professor Gama Pinto, Lisbon 1649-003, Portugal; Department of Pharmaceutics, The School of Pharmacy, University College London, 29/39 Brunswick Square, London WC1N 1AX, UK; School of Life and Medical Sciences, University of Hertfordshire, College Lane, Hatfield AL10 9AB, UK., Moura LIF; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Professor Gama Pinto, Lisbon 1649-003, Portugal; School of Life and Medical Sciences, University of Hertfordshire, College Lane, Hatfield AL10 9AB, UK., Peres C; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Professor Gama Pinto, Lisbon 1649-003, Portugal., Matos AI; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Professor Gama Pinto, Lisbon 1649-003, Portugal., Viana AS; Chemistry and Biochemistry Center, Sciences Faculty, Universidade de Lisboa, 1749-016 Lisbon, Portugal., Wagner AM; McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX 78712, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX 78712, USA., Vela Ramirez JE; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX 78712, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX 78712, USA., S Barata T; Department of Pharmaceutics, The School of Pharmacy, University College London, 29/39 Brunswick Square, London WC1N 1AX, UK., Gaspar M; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Professor Gama Pinto, Lisbon 1649-003, Portugal., Brocchini S; Department of Pharmaceutics, The School of Pharmacy, University College London, 29/39 Brunswick Square, London WC1N 1AX, UK., Zloh M; School of Life and Medical Sciences, University of Hertfordshire, College Lane, Hatfield AL10 9AB, UK., Peppas NA; McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX 78712, USA; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX 78712, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX 78712, USA; Division of Pharmaceutics, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA; Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA., Satchi-Fainaro R; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 69978, Israel., F Florindo H; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Professor Gama Pinto, Lisbon 1649-003, Portugal. Electronic address: hflorindo@ff.ul.pt.
Source: Acta biomaterialia [Acta Biomater] 2018 Aug; Vol. 76, pp. 193-207. Date of Electronic Publication: 2018 Jun 22.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101233144 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7568 (Electronic) Linking ISSN: 17427061 NLM ISO Abbreviation: Acta Biomater Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-7568
DOI:10.1016/j.actbio.2018.06.029